ADMA — ADMA BIOLOGICS INC

Ownership history in Maven Securities LTD  ·  8 quarters on record

This page tracks every 13F SEC filing in which Maven Securities LTD reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.22% (2022 Q1)
Avg. % of fund
0.06%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 35,000 -15,000 -30.0% 0.01% $513K $14.66
2024 Q1 UNCHANGED 50,000 — 0% 0.02% $330K $6.60
2023 Q1 ADDED 50,000 +35,000 +233.3% 0.00% $166K $3.31
2022 Q3 REDUCED 15,000 -454,206 -96.8% 0.00% $365K $2.43
2022 Q2 REDUCED 469,206 -3,022,318 -86.6% 0.03% $929K $1.98
2022 Q1 ADDED 3,491,524 +175,917 +5.3% 0.22% $6.4M $1.83
2021 Q4 ADDED 3,315,607 +2,565,282 +341.9% 0.13% $4.7M $1.41
2021 Q1 INITIATED 750,325 — — 0.06% $1.3M $1.76
% of Fund (quarterly)    ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%
← Back to Maven Securities LTD Holdings